Browse by Journal Title
Up a level |
Number of items: 7.
A
Abd Rachman Isnadi, Mohammad Faruq and Chin, Voon Kin and Abd. Majid, Roslaini and Lee, Tze Yan and Abdullah, Maizaton Atmadini and Omenesa, Ramatu Bello and Ibraheem, Zaid Osamah and Basir, Rusliza
(2018)
Critical roles of IL-33/ST2 pathway in neurological disorders.
Mediators of Inflammation, 2018.
art. no. 5346413.
pp. 1-9.
ISSN 0962-9351; ESSN: 1466-1861
C
Chin, Voon Kin and Yong, Voon Chen and Chong, Pei Pei and Amin Nordin, Syafinaz and Basir, Rusliza and Abdullah, Maha
(2020)
Mycobiome in the gut: a multi-perspective review.
Mediators of Inflammation, 2020.
art. no. 9560684.
pp. 1-16.
ISSN 0962-9351; ESSN: 1466-1861
M
Mohamad Zainal, Nurul Hayati and Abas Buang, Razif and Mohamad Asri, Siti Fadziyah
(2021)
Childhood allergy disease, early diagnosis, and the potential of salivary protein biomarkers.
Mediators of Inflammation, 2021.
pp. 1-12.
ISSN 0962-9351; ESSN: 1466-1861
R
Rajajendram, Revathee and Tham, Chau Ling and Akhtar, Mohamad Nadeem and Sulaiman, Mohd Roslan and Israf Ali, Daud Ahmad
(2015)
Inhibition of epithelial CC-family chemokine synthesis by the synthetic chalcone DMPF-1 via disruption of NF-κB nuclear translocation and suppression of experimental asthma in mice.
Mediators of Inflammation, 2015.
art. no. 176926.
pp. 1-14.
ISSN 0962-9351; ESSN: 1466-1861
S
Subramani, Tamilselvan and Rathnavelu, Vidhya and Yeap, Swee Keong and Mohammed Alitheen, Noorjahan Banu
(2013)
Influence of mast cells in drug-induced gingival overgrowth.
Mediators of Inflammation, 2013.
art. no. 275172.
pp. 1-8.
ISSN 0962-9351; ESSN: 1466-1861
Subramani, Tamilselvan and Rathnavelu, Vidhya and Mohammed Alitheen, Noorjahan Banu
(2013)
The possible potential therapeutic targets for drug induced gingival overgrowth.
Mediators of Inflammation, 2013.
art. no. 639468.
pp. 1-9.
ISSN 0962-9351; ESSN: 1466-1861
T
Tham, Chau Ling and Sin, Yee Yeoh and Ong, Chun Hao and Harith, Hanis Hazeera and Israf Ali, Daud Ahmad
(2021)
A synthetic curcuminoid analogue, 2,6-Bis-4-(Hydroxyl-3-Methoxybenzylidine)-Cyclohexanone (BHMC) ameliorates acute airway inflammation of allergic asthma in ovalbumin-sensitized mice.
Mediators of Inflammation, 2021.
pp. 1-10.
ISSN 0962-9351; ESSN: 1466-1861